Efficacy and safety of siponimod for multiple sclerosis: Protocol for a systematic review and meta-analysis

BACKGROUND: Multiple sclerosis is the most common demyelinating disease of the central nervous system with serious social and economic burden. Siponimod is a sphingosine-1-phosphate receptor agonist, and clinical trials in the past decade have shown good prospects for the treatment of multiple scler...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Medicine (Baltimore)
Main Authors: Song, Yumeng, Lao, Yongfeng, Liang, Fuxiang, Li, Jing, Jia, Bibo, Wang, Zixuan, Hui, Xu, Lu, Zhenxing, Zhou, Biao, Luo, Wei, Song, Bing
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2019
Teme:
5300
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716697/
https://ncbi.nlm.nih.gov/pubmed/31441835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000015415
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki